title: Erlotinib or gefitinib for non-small-cell lung cancer.
authors.forename: Syed W
authors.initials: SW
authors.lastname: Yusuf
authors.forename: Peter
authors.initials: P
authors.lastname: Kim
authors.forename: Jean-Bernard
authors.initials: JB
authors.lastname: Durand
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D017202:Myocardial Ischemia / Q000139:chemically induced*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D020521:Stroke / Q000139:chemically induced*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors; D000077156:Gefitinib